Clinical and prognostic implications of serum uric acid levels on IgA nephropathy: A cohort study of 348 cases with a mean 5-year follow-up

Clinical Nephrology

Volumn 80, Issue 1, 2013, Pages 40-46

  Cheng, Gen yang ^a   Liu, Dong wei ^a   Zhang, Na ^a   Tang, Lin ^a   Zhao, Zhan zheng ^a   Liu, Zhang suo ^a  

^a ZHENGZHOU UNIVERSITY   (China)

Author keywords

Creatinine; Glo merular fltration rate; IgA nephrop athy; Prognosis; Uric acid

Indexed keywords

CREATININE; URIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PROTEINURIA; UREA NITROGEN BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; BLOOD UREA NITROGEN; CONFIDENCE INTERVALS; CREATININE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; NEPHRITIS, INTERSTITIAL; ODDS RATIO; PROGNOSIS; PROTEINURIA; RETROSPECTIVE STUDIES; URIC ACID;

EID: 84879083041     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107813     Document Type: Article

References (30)

1. Rekola S, Bergstrand A, Bucht H. Deterioration of GFR in IgA nephropathy as measured by 51Cr-EDTA clearance. Kidney Int. 1991; 40: 1050-1054.
2. Chadban SJ, Briganti EM, Kerr PG, Dunstan D W, Welborn TA , Zimmet PZ, Atkins RC. Prevalence of kidney damage in Australian adults: The AusDiab kidney study. J Am Soc Nephrol. 2003; 14 (Suppl 2): S131-S138.
3. Romundstad S, Holmen J, Hallan H, Kvenild K, Krüger O, Midthjell K. Microalbuminuria, cardiovascular disease and risk factors in a nondiabetic/ nonhypertensive population. The Nord-Trøndelag Health Study (HUNT, 1995-97), Norway. J Intern Med. 2002; 252: 164-172.
4. Iseki K, Kohagura K, Sakima A, Iseki C, Kinjo K, Ikemiya Y, Takishita S. Changes in the demographics and prevalence of chronic kidney disease in Okinawa, Japan (1993 to 2003). Hypertens Res. 2007; 30: 55-62.
5. Muntner P, He J, Astor BC, Folsom AR, Coresh J. Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol. 2005; 16: 529-538.
6. oung JH, Klag MJ, Muntner P et al. Blood pressure and decline in kidney function: fndings from the Systolic Hypertension in the Elderly Program (SHEP). J Am Soc Nephrol, 2002; 13: 2776-782.
7. Bellomo G, Venanzi S, Verdura C, Saronio P, Es-posito A, Timio M. Association of uric acid with change in kidney function in healthy normotensive individuals. Am J Kidney Dis. 2010; 56: 264-272.
8. Rosolowsky E T, Ficociello LH, Maselli NJ, Niew-czas MA, Binns AL, Roshan B, Warram JH, Krolewski AS. High-normal serum uric acid is as-sociated with impaired glomerular fltration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol. 2008; 3: 706-713.
9. Madero M, Sarnak MJ, Wang X, Greene T, Beck GJ, Kusek J W, Collins AJ, Levey AS, Menon V. Uric acid and long-term outcomes in CKD. Am J Kidney Dis. 2009; 53: 796-803.
10. Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, Negri C, Bonora E. Serum uric acid levels and incident chronic kidney disease in patients with type 2 diabetes and preserved kidney function. Diabetes Care. 2012; 35: 99-104.
11. Zhang L, Wang F, Wang X, Liu L, Wang H. The association between plasma uric acid and renal function decline in a Chinese population-based cohort. Nephrol Dial Transplant. 2012; 27: 1836-1839.
12. Satirapoj B, Supasyndh O, Chaiprasert A, Ruang-kanchanasetr P, Kanjanakul I, Phulsuksombuti D, Utainam D, Choovichian P. Relationship between serum uric acid levels with chronic kidney disease in a Southeast Asian population. Nephrology (Carlton). 2010; 15: 253-258.
13. Ye n CJ, Chiang CK, Ho LC, Hsu SH, Hung K Y, Wu KD, Tsai TJ. Hyperuricemia associated with rapid renal function decline in elderly Taiwanese subjects. J Formos Med Assoc. 2009; 108: 921-928.
14. Edwards MS, Wilson DB, Craven TE, Stafford J, Fried L F, Wong T Y, Klein R, Burke GL, Hansen KJ. Associations between retinal microvascular abnormalities and declining renal function in the elderly population: the Cardiovascular Health Study. Am J Kidney Dis. 2005; 46: 214-224.
15. Park J T, Kim DK, Chang TI, Kim H W, Chang JH, Park S Y, Kim E, Kang S W, Han DS, Yo o TH. Uric acid is associated with the rate of residual renal function decline in peritoneal dialysis patients. Nephrol Dial Transplant. 2009; 24: 3520-3525.
16. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Defnition and classifca-tion of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67: 2089-2100.
17. Li PK, Ho KK, Szeto CC, Yu L, Lai FM. Prognostic indicators of IgA nephropathy in the Chinese - clinical and pathological perspectives. Nephrol Dial Transplant. 2002; 17: 64-69.
18. Cirillo P, Sato W, Reungjui S, Heinig M, Gersch M, Sautin Y, Nakagawa T, Johnson RJ. Uric acid, the metabolic syndrome, and renal disease. J Am Soc Nephrol. 2006; 17 (Suppl 3): S165-S168.
19. Barberi S, Menè P. [Role of uric acid in hypertension and in the progression of chronic renal disease]. G Ital Nefrol. 2006; 23: 4-11.
20. Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ. A role for uric acid in the progression of renal disease. J Am Soc Nephrol. 2002; 13: 2888-2897.
21. Myllymäki J, Honkanen T, Syrjänen J, Helin H, Rantala I, Pasternack A, Mustonen J. Uric acid correlates with the severity of histopathological parameters in IgA nephropathy. Nephrol Dial Transplant. 2005; 20: 89-95.
22. Tomino Y. IgA nephropathy: lessons from an animal model, the ddY mouse. J Nephrol. 2008; 21: 463-467.
23. Sturm G, Kollerits B, Neyer U, Ritz E, Kronen-berg F; MMKD Study Group. Uric acid as a risk factor for progression of non-diabetic chronic kidney disease? The Mild to Moderate Kidney Disease (MMKD) Study. Exp Gerontol. 2008; 43: 347-352.
24. Feig DI. Uric acid: a novel mediator and marker of risk in chronic kidney disease? Curr Opin Nephrol Hypertens. 2009; 18: 526-530.
25. Syrjänen J, Mustonen J, Pasternack A. Hypertri-glyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. Nephrol Dial Transplant. 2000; 15: 34-42.
26. Domrongkitchaiporn S, Sritara P, Kitiyakara C, Stitchantrakul W, Krittaphol V , Lolekha P , Chee-pudomwit S, Yipintsoi T. Risk factors for development of decreased kidney function in a southeast Asian population: a 12-year cohort study. J Am Soc Nephrol. 2005; 16: 791-799.
27. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron. 2001; 87: 333-339.
28. Lv J, Zhang H, Zhou Y, Li G, Zou W, Wang H. Natural history of immunoglobulin A nephropa-thy and predictive factors of prognosis: a long-term follow up of 204 cases in China. Nephrology (Carlton). 2008; 13: 242-246.
29. Wu J, Chen X, Xie Y, Yamanaka N, Shi S, Wu D, Liu S, Cai G. Characteristics and risk factors of intrarenal arterial lesions in patients with IgA ne-phropathy. Nephrol Dial Transplant. 2005; 20: 719-727.
30. Wu J, Chen XM, Shi SZ. [Signifcance of vascular lesions in IgA nephropathy and their infuencing factors, a study of 1,005 cases]. Zhonghua Yi Xue Za Zhi. 2003; 83: 289-293